| Issue Date | Title | Author(s) |
| 2017-01 | Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems. | Dua, K; Bebawy, M; Awasthi, R; Tekade, RK; Tekade, M; Gupta, G; De Jesus Andreoli Pinto, T; Hansbro, PM |
| 2020-07-13 | HMGB1 amplifies ILC2-induced type-2 inflammation and airway smooth muscle remodelling. | Loh, Z; Simpson, J; Ullah, A; Zhang, V; Gan, WJ; Lynch, JP; Werder, RB; Sikder, AA; Lane, K; Sim, CB; Porrello, E; Mazzone, SB; Sly, PD; Steptoe, RJ; Spann, KM; Sukkar, MB; Upham, JW; Phipps, S |
| 2020-01 | Investigating MIF in Mouse Models of Severe Corticosteroid-Resistant Neutrophilic Asthma. | Allam, VSRR; Sukkar, MB |
| 2020-01 | Pharmacologic Inhibition of Vacuolar H+ATPase Attenuates Features of Severe Asthma in Mice. | McAlinden, KD; Kota, A; Haghi, M; Ghavami, S; Sharma, P |
| 2020-09 | COVID-19 transmission through host cell directed network of GPCR. | Singh, Y; Gupta, G; Satija, S; Pabreja, K; Chellappan, DK; Dua, K |
| 2020-01 | COVID-19: Underpinning Research for Detection, Therapeutics, and Vaccines Development. | Aljabali, AAA; Bakshi, HA; Satija, S; Meenu,; Prasher, P; Ennab, RM; Chellappan, DK; Gupta, G; Negi, P; Goyal, R; Sharma, A; Mishra, V; Dureja, H; Dua, K; Tambuwala, MM |
| 2021-02 | Targeting eosinophils in respiratory diseases: Biological axis, emerging therapeutics and treatment modalities. | Lee, L-Y; Hew, GSY; Meenu,; Shukla, SD; Satija, S; Khurana, N; Anand, K; Dureja, H; Singh, SK; Mishra, V; Singh, PK; Gulati, M; Prasher, P; Aljabali, AAA; Tambuwala, MM; Thangavelu, L; Panneerselvam, J; Gupta, G; Zacconi, FC; Shastri, M; Jha, NK; Xenaki, D; MacLoughlin, R; Oliver, BG; Chellappan, DK; Dua, K |
| 2021-01-01 | RAGE and TLR4 differentially regulate airway hyperresponsiveness: implications for COPD. | Allam, VSRR; Faiz, A; Lam, M; Rathnayake, SNH; Ditz, B; Pouwels, SD; Brandsma, C-A; Timens, W; Hiemstra, PS; Tew, GW; Neighbors, M; Grimbaldeston, M; van den Berge, M; Donnelly, S; Phipps, S; Bourke, JE; Sukkar, MB |
| 2021-07 | Alleviation of diabetic nephropathy by zinc oxide nanoparticles in streptozotocin-induced type 1 diabetes in rats. | Alomari, G; Al-Trad, B; Hamdan, S; Aljabali, AAA; Al Zoubi, MS; Al-Batanyeh, K; Qar, J; Eaton, GJ; Alkaraki, AK; Alshaer, W; Haifawi, S; Jemon, K; Chellappan, DK; Dua, K; Tambuwala, MM |
| 2021-10 | LL-37 and HMGB1 induce alveolar damage and reduce lung tissue regeneration via RAGE. | Pouwels, SD; Hesse, L; Wu, X; Allam, VSRR; van Oldeniel, D; Bhiekharie, LJ; Phipps, S; Oliver, BG; Gosens, R; Sukkar, MB; Heijink, IH |
